Representative End User Clients
Representative Automation Clients
Representative Software Clients
In this insightful podcast episode, hosts Vikram Kalkat and Saurabh Sasidharan engage in a discussion with Vishnu Ramesh, the founder of Subtl.ai, on the impact of AI-powered document agents in the life sciences industry. Vishnu explains how transformer-based AI models—which have existed long before the rise of OpenAI—are now revolutionizing clinical trial operations and regulatory processes. His company, Subtl.ai, emerged from research at IIIT Hyderabad, focusing on using AI for document processing, data retrieval, and automation. Given the life sciences industry's complex, data-heavy, and privacy-sensitive workflows, AI-powered solutions like Subtl.ai’s document agents are designed to accelerate and optimize these processes.
One of the key challenges in life sciences is handling vast amounts of secure, domain-specific data, such as patient records, clinical trial reports, and regulatory filings. Vishnu highlights two primary areas where Subtl.ai is making an impact:
Clinical trial operations – AI helps analyze large volumes of patient data in Phase 2 and Phase 3 trials, reducing the time and cost associated with regulatory approvals. Even a 3 to 6-month acceleration in drug development could translate into hundreds of millions in savings.
Contract research and sales automation – Contract Research Organizations (CROs) rely on AI to automate proposal generation, RFP responses, and regulatory compliance documentation, significantly enhancing speed and accuracy in deal-making processes.
Vishnu also touches on the broader AI landscape, emphasizing the rise of open-source AI models, which are closing the gap with proprietary solutions like OpenAI and Anthropic. Startups like Subtl.ai are leveraging open-source advancements while building proprietary, domain-specific AI models that outperform generic solutions in niche applications. He also discusses the growing "buy vs. build" trend in enterprises, where companies increasingly adopt external AI solutions instead of developing costly in-house models. As AI continues to evolve, Subtl.ai’s focus on precision, automation, and efficiency positions it as a game-changer in the life sciences industry.
You can watch the podcast here.
Visit our Industrial AI YouTube channel for more episodes and insights.
